Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
NPJ Genomic Medicine|September 25, 2024
CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcomaKarim H Saba, Valeria Difilippo, Emelie Styring, et al.Genes, Chromosomes & Cancer|June 14, 2013
Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumorArezoo Mohajeri, Johnbosco Tayebwa, Anna Collin, et al.The American Journal of Pathology|July 17, 2012
Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumorsSamuel Gebre-Medhin, Karolin H Nord, Emely Möller, et al.The Journal of Pathology|November 27, 2023
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathwayKarim H Saba, Valeria Difilippo, Michal Kovac, et al.The Journal of Pathology. Clinical Research|June 17, 2020
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastomaKarim H Saba, Louise Cornmark, Jakob Hofvander, et al.Nature Genetics|November 8, 2011
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndromeTwinkal C Pansuriya, Ronald van Eijk, Pio d'Adamo, et al.Pageof 4